96例妊娠期缺铁性贫血预防和治疗分析.docVIP

96例妊娠期缺铁性贫血预防和治疗分析 　　摘 要 目的：观察红源达在预防治疗妊娠期缺铁性贫血的临床疗效及应用价值。方法：选择在我院确诊的铁储备不足的孕妇96例按孕妇意愿分为治疗组和对照组，均定期检查血常规及铁缺乏指标，治疗期间每4周访视一次直至分娩。结果：治疗组孕妇与新生儿体内铁储存状态在妊娠早、中、晚期体内均有相关性；对照组仅在妊娠中、晚期有相关性。结论：红源达多糖铁复合物胶囊在临床预防和治疗妊娠期缺铁性贫血具有应用价值，值得临床推广。 　　关键词 多糖铁复合物 妊娠期 缺铁性贫血 　　中图分类号：R714.254； R973.3 文献标识码：B 文章编号：1006-1533（2017）21-0021-02 　　Prevention and treatment analysis of 96 cases of iron deficiency anemia during pregnancy* 　　WANG Qinjie1**， ZAHNG Pengyan2， WU Xiaoyan1， ZHANG Cong2*** 　　（1. Maternity and Infant Hospital of Putuo District， Shanghai 200062， China； 2. SPH Qingdao GrowfulPharmaceutical Co.， Ltd.， Qingdao 266071， China） 　　ABSTRACT Objective： To observe the clinical efficacy and application value of Hongyuanda in the prevention and treatment of iron deficiency anemia during pregnancy. Methods： Ninety-six cases of pregnant women with insufficient iron were divided into a treatment group and a control group based on the wishes of pregnant women and their blood and iron deficiency indicators were regularly checked. Follow-up were carried out every 4 weeks till their delivery during treatment. Results： The iron storage status was correlated with that in neonates in the early， middle and late stages of the pregnancy in the treatment group while only in the middle and late stages of the pregnancy in the control group. Conclusion： Hongyuanda polysaccharide iron complex capsules can be used for the prevention and treatment of iron deficiency anemia during pregnancy and possesses an applicable value and is worthy of clinical application. 　　KEy WORDS polysaccharide-iron complex； pregnancy； Iron deficiency anemia 　　铁缺乏是全球最常见的单一营养性疾病之一，全球有将近12亿人口存在铁缺乏。在发展中国家，铁缺乏是贫血最常见的原因之一，贫血中有将近50%是由铁缺乏引起的，而缺铁性贫血是妊娠期最常见的贫血，占妊娠贫血的95%[1]。 　　体内铁缺乏对孕妇和胎儿均有危害，孕妇铁缺乏可能会引起妊娠期高血压病或妊娠期高血压性心脏病、贫血性心脏病，分娩时易发生心力衰竭，产时产后即使失血不多，也易?l生休克及产褥期感染等，同时缺铁还可能导致早产、胎儿宫内发育受限、死胎[2]。补铁可增加母体铁储存[3-6]。 　　因此及时、合理地补充铁剂，对妊娠期缺铁性贫血患者的预防治疗十分重要。本研究旨在通过服用红源达预防治疗妊娠期缺铁性贫血患者，探讨其临床应用价值，为临床治疗提供参考依据。 　　1 资料与方法 　　1.1 一般资料 　　选取上海市普陀区妇婴保健院2016年